PROC Total Utang marang Modal Procaps Group Corp

Lambang korporat lan logo Procaps Group S.A. (PROC)

Procaps Group S.A. (PROC) is developing a CDMO model, collaborating with global partners to create unique dosage formulas for accelerated drug launches. This chart reflects a total debt-to-equity ratio of 0.00, alongside the implementation of strict temperature controls during product transportation. Despite turnover in financial leadership due to audit delays, the company relies on its dedicated engineers and the recruitment of compliance experts.

PROC: Total Utang marang Modal Procaps 04.07.2022 - 16.02.2025

Rincian analitis lan laporan data perusahaan Procaps Group Corp (PROC)

- rega lan prakiraan konsensus rega:
Bagan rega Procaps|PROC - Bagan tingkat prakiraan
- data kapitalisasi pasar:
Kapitalisasi pasar Procaps|PROC - Nilai Dipunlarasaken Utang lan Kas
- data kapitalisasi buku:
Nilai Buku saben Saham Procaps|PROC - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku procapsgroup.com|PROC - Nilai Agregat Aset
- data utang lan likuiditas:
Utang marang Ekuitas Procaps Group S.A.|PROC - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Procaps Group S.A.|PROC - Gunggung utang perusahaan|Utang marang nilai buku Procaps
Analisis komprehensif perusahaan:PROC - Procaps
Produk merek Procaps Group Corp

For Procaps Group S.A. (PROC), which is scaling its CDMO production and iCaps deliveries, the total debt-to-equity ratio reflects the cost of long-term expansion within the pharmaceutical sector. This indicator is calculated as the sum of all liabilities divided by net assets, allowing for an assessment of the business's reliance on borrowed funds and the stability of the company's financial structure during periods of active growth.

Pesaing wigati

Utang marang Ekuitas Haleon HLN|Utang Agregat marang Ekuitas Kenvue Inc|Verona Pharma Corp (VRNA) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi Jyong Bio (MENS)|Total Utang marang Modal LGND (Ligand Pharmaceuticals)|amneal.com - Total Utang marang Modal|Utang marang Ekuitas Perrigo (PRGO)|ALVO: Rasio Kabeh Utang marang Dana Pribadi|LQDA (Liquidia Technologies) - Utang marang Ekuitas|Galapagos Corp (GLPG) - Rasio Total Utang marang Ekuitas|ANIP (ANI Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal mannkindcorp.com (MNKD)|Amphastar Pharmaceuticals, Inc. (AMPH) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi PCRX (Pacira Pharmaceuticals)|SPRY: Utang marang Ekuitas|TBPH - Utang marang Modal|Rasio Total Utang marang Ekuitas Aquestive Therapeutics AQST|SCPH - Utang Agregat marang Modal|Total Utang marang Modal tectonictx.com TECX|Tonix Pharma (TNXP) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal SXTC (SXT Pharmaceuticals)|Utang marang Modal EPRX|BioHarvest Sciences (BHST) - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi EXOZ (invizyne.com)|Oramed Pharmaceuticals Inc. (ORMP) - Utang marang Ekuitas|Entera Bio Ltd - Utang Agregat marang Ekuitas|Utang marang Ekuitas MindWalk (HYFT)|ABVC: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas CPIX|quantumbiopharma.com (QNTM) - Utang marang Modal|Total Utang marang Modal FGEN|Rasio Total Utang marang Ekuitas Telomir Pharmaceuticals Inc|Total Utang marang Modal RANI|Total Utang marang Modal SNYR (synergychc.com)|Rallybio (RLYB) - Utang marang Ekuitas|Lexaria Bioscience Corp - Utang Agregat marang Ekuitas|Utang marang Ekuitas PULM (Pulmatrix)|Pheton Holdings Ltd (PTHL) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas aptorumgroup.com APM|Lyra Therapeutics Inc (LYRA) - Rasio Kabeh Utang marang Dana Pribadi|Impact BioMedical Inc - Total Utang marang Modal|Rasio Utang marang Modal TNFA|cbdMD, Inc. (YCBD) - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi PRFX (PainReform Ltd)|CYTO: Utang marang Ekuitas|LIPO - Utang marang Modal|OptiNose, Inc. - Rasio Total Utang marang Ekuitas|PIRS: Total Utang marang Modal|Utang marang Ekuitas Petros Pharmaceuticals, Inc. (PTPI)|Utang Agregat marang Ekuitas Qilian International Holding Group|SLRN - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi TFFP